UnitedHealthcare Pharmacy
Clinical Pharmacy Programs
Program Number 2024 P 1323-6
Program Prior Authorization/Notification
Medication Rukobia (fostemsavir)
P&T Approval Date 8/2020, 12/2020, 12/2021, 12/2022, 12/2023, 12/2024
Effective Date 3/1/2025
1. Background:
Rukobia (fostemsavir), a human immunodeficiency virus type 1 (HIV-1) gp120-directed
attachment inhibitor, in combination with other antiretroviral(s), is indicated for the treatment
of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1
infection failing their current antiretroviral regimen due to resistance, intolerance, or safety
considerations.1
Members will be required to meet the coverage criteria below.
2. Coverage Criteriaa:
A. Rukobia
1. Rukobia will be approved based on both of the following criteria:
a. Patient has been diagnosed with multidrug-resistant HIV-1 infection
-AND-
b. Patient is currently taking or will be prescribed an optimized background
antiretroviral regimen
Authorization will be issued for 12 months.
a State mandates may apply. Any federal regulatory requirements and the member specific
benefit plan coverage may also impact coverage criteria. Other policies and utilization
management programs may apply.
3. Additional Clinical Rules:
• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-
authorization based solely on previous claim/medication history, diagnosis codes (ICD-10)
and/or claim logic. Use of automated approval and re-approval processes varies by program
and/or therapeutic class.
• Supply limits may be in place.
4. References:
1. Rukobia [Package Insert]. Durham, NC: ViiV Healthcare; February 2024.
© 2024 UnitedHealthcare Services, Inc.
1
Program Prior Authorization/Notification - Rukobia (fostemsavir)
Change Control
8/2020 New program.
12/2020 Revised criteria language related to optimized background regimen.
12/2021 Annual review with no change to clinical criteria.
12/2022 Annual review with no change to clinical criteria. Added state mandate
footnote and updated reference.
12/2023 Annual review with no changes to coverage criteria.
12/2024 Annual review with no changes to coverage criteria. Updated reference.
© 2024 UnitedHealthcare Services, Inc.
2